Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Nirav S. Jhaveri | Chief Financial Officer | 2025-02-13 | 8,207 | $1.15 | $9.44kSell |
Ashwath Jayagopal | Chief Scientific Dev. Ofc. | 2025-02-13 | 5,193 | $1.15 | $5.97kSell |
Bernhard Hoffmann | SVP of Corp. Dev. | 2025-02-04 | 6,751 | $1.14 | $7.70kSell |
Rabourn Amy Zaremba | SVP of Finance | 2025-02-04 | 8,190 | $1.14 | $9.34kSell |
George Magrath | Chief Executive Officer | 2024-12-26 | 100,000 | $0.98 | $97.60kBuy |
Benjamin R. Yerxa | President | 2024-11-21 | 10,000 | $0.98 | $9.83kBuy |
George Magrath | Chief Executive Officer | 2024-11-18 | 9,706 | $1.02 | $9.94kBuy |
George Magrath | Chief Executive Officer | 2024-11-15 | 90,294 | $1.01 | $91.20kBuy |
George Magrath | Chief Executive Officer | 2024-11-01 | 37,050 | $1.18 | $43.72kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Sungkee Chung | 274.55% | 163,800,000 | $163.80M | Insider |
Sung Sook Park | 117.66% | 70,200,000 | $70.20M | Insider |
Frank Ferraro | 43.58% | 26,000,000 | $26.00M | Insider |
Inok Ahn | 23.47% | 14,000,000 | $14.00M | Insider |
Chang Ho Ahn | 19.29% | 11,510,000 | $11.51M | Insider |
Foundation Fighting Blindness Retinal Degeneration Fund | 15.91% | 9,492,171 | $9.49M | Insider |
Rexgene Biotech Co Ltd | 9.23% | 5,505,956 | $5.51M | Insider |
Perceptive Advisors LLC | 7.25% | 4,325,000 | $4.33M | Institution |
Nantahala Capital Management LLC | 5.29% | 3,157,895 | $3.16M | Institution |
Young Soon Park | 4.54% | 2,706,500 | $2.71M | Insider |